This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kawashima, T. Articles by Fujiwara, T. Search for Related Content PubMed PubMed Citation Articles by Kawashima, T. Articles by Fujiwara, T.

Telomerase-Specific Replication-Selective Virotherapy for Human Cancer

¹Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan;² Center for Gene and Cell Therapy, Okayama University Hospital, Okayama, Japan; and³ Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Kanazawa, Japan

Purpose: Replication-selective tumor-specific viruses present a novel approach for treating neoplastic disease. These vectors are designed to induce virus-mediated lysis of tumor cells after selective viral propagation within the tumor. Telomerase activation is considered to be a critical step in carcinogenesis, and its activity is closely correlated with human telomerase reverse transcriptase (hTERT) expression. We investigated the antitumor effect of the hTERT-specific replication-competent adenovirus on human cancer cells.

Experimental Design: We constructed an adenovirus 5 vector [tumor- or telomerase-specific replication-competent adenovirus (TRAD)], in which the hTERT promoter element drives expression of E1A and E1B genes linked with an internal ribosome entry site, and we examined the selective replication and antitumor effect in human cancer cells in vitro and in vivo.

Results: TRAD induced selective E1A and E1B expression in human cancer cells, but not in normal cells such as human fibroblasts. TRAD replicated efficiently and induced marked cell killing in a panel of human cancer cell lines, whereas replication as well as cytotoxicity was highly attenuated in normal human fibroblasts lacking telomerase activity. In nu/nu mice carrying s.c. human lung tumor xenografts, intratumoral injection of TRAD resulted in a significant inhibition of tumor growth. No evidence of TRAD was identified in tissues outside of the tumors, despite the presence of TRAD in the circulation. Moreover, TRAD replication in the distant, noninjected tumors was demonstrated.

Conclusions: Our results suggest that the hTERT promoter confers competence for selective replication of TRAD in human cancer cells, an outcome that has important implications for the treatment of human cancers.

This article has been cited by other articles:

				D. Liu, T. Kojima, M. Ouchi, S. Kuroda, Y. Watanabe, Y. Hashimoto, H. Onimatsu, Y. Urata, and T. Fujiwara Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer Mol. Cancer Ther., April 1, 2009; 8(4): 980 - 987. [Abstract] [Full Text] [PDF]

				Y. Kurihara, Y. Watanabe, H. Onimatsu, T. Kojima, T. Shirota, M. Hatori, D. Liu, S. Kyo, H. Mizuguchi, Y. Urata, et al. Telomerase-Specific Virotheranostics for Human Head and Neck Cancer Clin. Cancer Res., April 1, 2009; 15(7): 2335 - 2343. [Abstract] [Full Text] [PDF]

				Y. Ikeda, T. Kojima, S. Kuroda, Y. Endo, R. Sakai, M. Hioki, H. Kishimoto, F. Uno, S. Kagawa, Y. Watanabe, et al. A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System J. Immunol., February 1, 2009; 182(3): 1763 - 1769. [Abstract] [Full Text] [PDF]

				L. R. Paiva, C. Binny, S. C. Ferreira Jr., and M. L. Martins A Multiscale Mathematical Model for Oncolytic Virotherapy Cancer Res., February 1, 2009; 69(3): 1205 - 1211. [Abstract] [Full Text] [PDF]

				O. Nakajima, A. Matsunaga, D. Ichimaru, Y. Urata, T. Fujiwara, and K. Kawakami Telomerase-specific virotherapy in an animal model of human head and neck cancer Mol. Cancer Ther., January 1, 2009; 8(1): 171 - 177. [Abstract] [Full Text] [PDF]

				C. Su, M. Na, J. Chen, X. Wang, Y. Liu, W. Wang, Q. Zhang, L. Li, J. Long, X. Liu, et al. Gene-Viral Cancer Therapy Using Dual-Regulated Oncolytic Adenovirus with Antiangiogenesis Gene for Increased Efficacy Mol. Cancer Res., April 1, 2008; 6(4): 568 - 575. [Abstract] [Full Text] [PDF]

				A. E. Bilsland, A. Merron, G. Vassaux, and W. N. Keith Modulation of Telomerase Promoter Tumor Selectivity in the Context of Oncolytic Adenoviruses Cancer Res., February 1, 2007; 67(3): 1299 - 1307. [Abstract] [Full Text] [PDF]

				H. Ito, H. Aoki, F. Kuhnel, Y. Kondo, S. Kubicka, T. Wirth, E. Iwado, A. Iwamaru, K. Fujiwara, K. R. Hess, et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst, May 3, 2006; 98(9): 625 - 636. [Abstract] [Full Text] [PDF]

				T. Wirth, F. Kuhnel, B. Fleischmann-Mundt, N. Woller, M. Djojosubroto, K. L. Rudolph, M. Manns, L. Zender, and S. Kubicka Telomerase-Dependent Virotherapy Overcomes Resistance of Hepatocellular Carcinomas against Chemotherapy and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand by Elimination of Mcl-1 Cancer Res., August 15, 2005; 65(16): 7393 - 7402. [Abstract] [Full Text] [PDF]

				A. Biroccio and C. Leonetti Telomerase as a new target for the treatment of hormone-refractory prostate cancer Endocr. Relat. Cancer, September 1, 2004; 11(3): 407 - 421. [Abstract] [Full Text] [PDF]

				T. Umeoka, T. Kawashima, S. Kagawa, F. Teraishi, M. Taki, M. Nishizaki, S. Kyo, K. Nagai, Y. Urata, N. Tanaka, et al. Visualization of Intrathoracically Disseminated Solid Tumors in Mice with Optical Imaging by Telomerase-Specific Amplification of a Transferred Green Fluorescent Protein Gene Cancer Res., September 1, 2004; 64(17): 6259 - 6265. [Abstract] [Full Text] [PDF]